Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  
  Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
ISSN: 1871-5206
eISSN: 1875-5992
 
  < Previous Issue | Next Issue > | All Issues   |   All Titles
 
Volume 12
  Issue 9
Articles  
  The Nuclear Orphan Receptors NR4A as Therapeutic Target in Cancer Therapy
    pp.1001-1014 (14) Authors: Alexander J. A. Deutsch, Hannes Angerer, Tamara E. Fuchs, Peter Neumeister
   
  Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling
    pp.1015-1024 (10) Authors: Mariana Reis, Ricardo J. Ferreira, Julianna Serly, Noelia Duarte, Ana M. Madureira, Daniel J. V. A. Santos, Joseph Molnar, Maria-Jose U. Ferreira
   
  The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer
    pp.1025-1044 (20) Authors: Ioly Kotta-Loizou, Constantinos Giaginis, Stamatios Theocharis
   
  CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
    pp.1045-1057 (13) Authors: Alicia Gonzalez-Martin, Emilia Mira, Santos Manes
   
  Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
    pp.1058-1070 (13) Authors: Jose Prados, Consolacion Melguizo, Raul Ortiz, Celia Velez, Pablo J. Alvarez, Jose L. Arias, Maria A. Ruiz, Visitacion Gallardo, Antonia Aranega
   
  Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones
    pp.1071-1080 (10) Authors: Manja Zec, Tatjana Srdic-Rajic, Aleksandra Konic-Ristic, Tamara Todorovic, Katarina Andjelkovic, Ivana Filipovic-Ljeskovic, Sinisa Radulovic
   
  Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand?
    pp.1081-1087 (7) Authors: Zhaowei Zhu, Zhoujun Shen, Chen Xu
   
  Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma
    pp.1088-1097 (10) Authors: Ahmed Temirak, Mona Abdulla, Mahmoud Elhefnawi
   
  JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
    pp.1098-1109 (12) Authors: Fabio P. S. Santos, Srdan Verstovsek
   
  Anti-cancer Effects of Curcumin on Head and Neck Cancers
    pp.1110-1116 (7) Authors: Wei Gao, Jimmy Yu-Wai Chan, William Ignance Wei, Thian-Sze Wong
   
  Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents
    pp.1117-1131 (15) Authors: David E. Zembower, Yongping Xie, Ali Koohang, Mary J. Kuffel, Matthew M. Ames, Yasheen Zhou, Rama Mishra, Aye Aye Mar, Michael T. Flavin, Ze-Qi Xu
   
  Dual Roles of Sulforaphane in Cancer Treatment
    pp.1132-1142 (11) Authors: Tongzhen Xu, Dongmei Ren, Xuefei Sun, Guotao Yang
   
  Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules
    pp.1143-1155 (13) Authors: Michael Hedvat, Luni Emdad, Swadesh K. Das, Keetae Kim, Santanu Dasgupta, Shibu Thomas, Bin Hu, Shan Zhu, Rupesh Dash, Bridget A. Quinn, Regina A. Oyesanya, Timothy P. Kegelman, Upneet K. Sokhi, Siddik Sarkar, Eda Erdogan, Mitchell E. Menezes, Praveen Bhoopathi, Xiang-Yang Wang, Martin G. Pomper, Jun Wei, Bainan Wu, John L. Stebbins, Paul W. Diaz, John C. Reed, Maurizio Pellecchia, Devanand Sarkar, Paul B. Fisher
   
  Key: New Content Free Content Open Access Plus Subscribed Content


Bentham Science Publishers
www.benthamscience.com